Sudano, Isabella http://orcid.org/0000-0001-8197-8892
Osto, Elena http://orcid.org/0000-0001-8196-5696
Ruschitzka, Frank http://orcid.org/0000-0001-5972-0596
Chapter History
First Online: 30 July 2020
Change Date: 18 December 2020
Change Type: Correction
Change Details: The Open Access chapter ‘Blood Pressure-Lowering Therapy’ was published online unfortunately without the Conflict of Interest statement. The COI statement should appear as:
Conflict of Interest
: FR reports grant support for the ESC-HFA Postgraduate Course in Heart Failure from Novartis, Servier, Bayer, Abbott and Astra Zeneca and the VASCEND trial from Novartis (all payments directly to the University of Zurich).
: FR has been paid for the time spent as a committee member for clinical trials, advisory boards, other forms of consulting and lectures or presentations. These payments were made directly to the University of Zurich and no personal payments were received in relation to these trials or other activities since January 2018.
: Before 2018, FR reports grants and personal fees from SJM/Abbott, Servier, Novartis and Bayer, personal fees from Zoll, Astra Zeneca, Sanofi, Amgen, BMS, Pfizer, Fresenius, Vifor, Roche, Cardiorentis and Boehringer Ingelheim, other from Heartware and grants from Mars, outside the submitted work.